ON WARDS

ONWARDS

The ONWARDS program aims to support the national program by accelerating the implementation of the BPaL/M regimen as an alternative treatment for drug‑resistant TB patients in Indonesia, by aligning implementation at provincial and district or city levels and strengthening the capacity of health workers and stakeholder support.

Information

The ONWARDS program is implemented by strengthening the capacity of health workers (Doctor, Nurse, and Laboratory Staff) in 32 health‑care facilities across 32 provinces in managing BPaL/M treatment. Regular monitoring, conducted quarterly through online meetings and offline clinical audits, ensures the effectiveness of BPaL/M treatment implementation in the 32 selected facilities.

TB Alliance

Tuberculosis Working Group, Ministry of Health of the Republic of Indonesia

Provincial Health Offices of the 32 selected provinces

District/City Health Offices of the 32 selected areas, 32 selected hospitals

Type of Study

Stakeholders Involved

Program Implementation Study

Background

Indonesia is among the countries with the highest burden of tuberculosis (TB) and drug‑resistant tuberculosis (DR‑TB) in the world. According to the WHO Global TB Report 2020, an estimated 24,000 DR‑TB cases occurred in Indonesia in 2019, of which only 11,463 cases (48%) were detected and reported. Indonesia also faces challenges related to suboptimal treatment outcomes, with only around 50% of DR‑TB patients initiating second‑line treatment and only 46% achieving treatment success (based on the 2017 patient cohort data).